RENTSCHLER BIOPHARMA LAUNCHES NEW WHITE PAPER: Improving AAV Vector Quality with In-Process Monitoring of Capsid Formation

Nov 19, 2024

Posted by Rentschler Biopharma Inc

Pharvaris Reports Third Quarter 2024 Financial Results and Highlights Recent Business Updates

Nov 13, 2024

Posted by Pharvaris, Inc.

Pharvaris to Participate in the Guggenheim Healthcare Innovation Conference

Nov 12, 2024

Posted by Pharvaris, Inc.

A Medical Device Sponsor’s Guidebook: How to Navigate Clinical Trials

Nov 08, 2024

Posted by Medrio,Inc.

12 Questions to Consider for Using AI in Clinical Trials

Nov 04, 2024

Posted by Medrio,Inc.

Withum Launches ‘Up for Debate: 2024 Presidential Election Coverage’ Resource Center

Oct 31, 2024

Posted by WithumSmith+Brown, PC

RENTSCHLER BIOPHARMA LAUNCHES WHITE PAPER: Fast path to market: Going from GMP1 to PPQ in just 12 months

Oct 31, 2024

Posted by Rentschler Biopharma Inc

Introducing Our New Product: FGF2 Alternative Peptide (FGFR1c Agonist)

Oct 30, 2024

Transforming Global Healthcare

Oct 29, 2024

Phosphorex Opens Innovation & Training Center, Showcasing LNP Development Capabilities with NOF’s COATSOME® SS Series

Oct 29, 2024

Posted by Phosphorex